Suchergebnisse - "F0P408N6V4"

PubPharm (399)

1

Multiple Myeloma Treatment in Real-world Clinical Practice : Results of a Prospective, Multinational, Noninterventional Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2018

von Mohty, M. | Terpos, E. | Mateos, M. | +130

2

Proteomic profiling of naïve multiple myeloma patient plasma cells identifies pathways associated with favourable response to bortezomib-based treatment regimens

enthalten in: British journal of haematology | 2015

von Dytfeld, D. | Rosebeck, S. | Kandarpa, M. | +10

3

Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib : experience at an Australian Cancer Hospital

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2015

von Teh, B. | Worth, L. | Harrison, S. | +2

4

Development of extramedullary myeloma in the era of novel agents : no evidence of increased risk with lenalidomide-bortezomib combinations

enthalten in: British journal of haematology | 2015

von Varga, C. | Xie, W. | Laubach, J. | +13

CommentIn: Br J Haematol. 2015 Jun;169(6):763-5. - PMID 25825255

5

NICE guidance on pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib

enthalten in: The Lancet. Oncology | 2015

von Burke, M. | George, E. | Adler, A.

6

Treatment-related symptom management in patients with multiple myeloma : a review

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2015

von Colson, K.

7

Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide

enthalten in: Annals of hematology | 2015

von Lau, I. | Smith, D. | Aitchison, R. | +6

8

Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies

enthalten in: American journal of hematology | 2015

von Kastritis, E. | Roussou, M. | Gavriatopoulou, M. | +10

9

Waldenstrom macroglobulinemia : prognosis and management

enthalten in: Blood cancer journal | 2015

von Oza, A. | Rajkumar, S.

ErratumIn: Blood Cancer J. 2016;6:e391. - PMID 26849012

10

The European medicines agency review of pomalidomide in combination with low-dose dexamethasone for the treatment of adult patients with multiple myeloma : summary of the scientific assessment of the committee for medicinal products for human use

enthalten in: The oncologist | 2015

von Hanaizi, Z. | Flores, B. | Hemmings, R. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[40]